financetom
Personal Finance
financetom
/
Personal Finance
/
Research Alert: CFRA Lowers Opinion On Shares Of Diodes Incorporated To Strong Sell From Sell
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Research Alert: CFRA Lowers Opinion On Shares Of Diodes Incorporated To Strong Sell From Sell
May 9, 2024 10:08 PM

12:45 AM EDT, 05/10/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows:

We raise our price target by $10 to $49, 13x our '25 EPS view, near peers but below DIOD's 3-year average (~14x) on lingering inventory headwinds across each of its end markets. Our lifted target reflects a conservative shift in focus to '25 from '24. We lower our '24 EPS view by $0.28 to $2.14 and lower '25's by $0.25 to $3.76. DIOD posts Q1 sales of $302M (-35% Y/Y) and EPS of $0.28 (-82%), just below consensus. Echoing bearish sentiment from CFRA's forensic accounting team in April, we see increasing risks to gross margin from rising levels of inventory, with total days up 15% Q/Q (59% Y/Y) to 184 and finished goods days up 37% (116% Y/Y) to 67. DIOD expects GM improvement from a mix shift towards Auto/Industrial (sales -6% Q/Q, -44% Y/Y), but we expect continued inventory headwinds in these markets (particularly industrial) to weigh on growth throughout '24, especially as DIOD's focus on Asia (75% of Q1 sales), where EVs have been more resilient, faces new risks from Chinese quotas for non-domestic supply.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Research Alert: CFRA Keeps Hold Opinion On Shares Of Invesco Ltd.
Research Alert: CFRA Keeps Hold Opinion On Shares Of Invesco Ltd.
Apr 23, 2024
10:45 AM EDT, 04/23/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We trim our 12-month target by $2 to $16, valuing IVZ shares at 8.6x our 2025 adjusted EPS estimate of $1.85 (cut today by $0.05) and at 10x our 2024...
Research Alert: CFRA Keeps Hold Opinion On Shares Of Msci Inc.
Research Alert: CFRA Keeps Hold Opinion On Shares Of Msci Inc.
Apr 23, 2024
11:40 AM EDT, 04/23/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We decrease our target price by $165 to $465, 27.4x our 2025 EPS estimate, a discount to MSCI's ( MSCI ) 10-year forward P/E average of 36.4x given reduced growth...
Research Alert: CFRA Reiterates Hold Opinion On Shares Of Jetblue Airways Corporation
Research Alert: CFRA Reiterates Hold Opinion On Shares Of Jetblue Airways Corporation
Apr 23, 2024
11:45 AM EDT, 04/23/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: Our 12-month target of $6.50, down $0.50, reflects a 3.4x multiple of EV to projected '25 EBITDA, a discount to JBLU's historical average. We think a discount is merited due...
Research Alert: CFRA Keeps Hold Opinion On Adss Of Novartis Ag
Research Alert: CFRA Keeps Hold Opinion On Adss Of Novartis Ag
Apr 23, 2024
12:45 PM EDT, 04/23/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We raise our target price by $3 to $108, implying a 2024 P/E of 15.4x, largely in line with the peer average. Novartis ( NVS ) raised its full-year 2024...
Copyright 2023-2026 - www.financetom.com All Rights Reserved